Bank Of America Corp Werewolf Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,147,425 shares of HOWL stock, worth $4.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,147,425
Previous 1,881,113
14.16%
Holding current value
$4.72 Million
Previous $12.2 Million
57.02%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HOWL
# of Institutions
75Shares Held
32.1MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$13.5 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$9.43 Million5.74% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$7.13 Million0.41% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$5.25 Million0.94% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2MShares$4.4 Million0.01% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $65M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...